Sensitization of Hypoxic Tumour Cells—Clinical Experience

References

• Adams G.E. Hypoxic cell sensitizers for radiotherapy. Cancer—A comprehensive treatise, F.F. Becker. Plenum Press, New York 1977; 6: 181–223
   Google Scholar
• Adams G.E., Ahmed I., Sheldon P.W., Stratford I.J. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. British Journal of Cancer 1984; 49: 571–577
   PubMed Web of Science ®Google Scholar
• Awwad H.K., El Naggar M., Mocktar N., Barsoum M. Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1329–1333
   PubMed Web of Science ®Google Scholar
• Brady L.W., Plenk H.P., Hanley J.A., Glassburn J.R., Kramer S., Parker R.G. Hyperbaric oxygen therapy for carcinoma of the cervix—stages IIB, IIIA, IIIB and IVA: results of a randomized study by the radiation therapy oncology group. International Journal of Radiation Oncology, Biology, and Physics 1981; 7: 991–998
   PubMedGoogle Scholar
• Bush R.S. The significance of anemia in clinical radiation therapy. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 2047–2050
   PubMed Web of Science ®Google Scholar
• Churchill-Davidson I. The oxygen effect in radiotherapy—historical review. Frontiers of Radiation Therapeutic Oncology 1968; 1: 1–15
   Google Scholar
• Coleman N.C. Hypoxia in tumors: A paradigm for the approach to biochemical and physiologic heterogeneity. Journal of the National Cancer Institute 1988; 80: 310–317
   PubMed Web of Science ®Google Scholar
• Dische S. Hyperbaric oxygen: the Medical Research Council trials and their clinical significance. British Journal of Radiology 1979; 51: 888–894
   Web of Science ®Google Scholar
• Dische S. The clinical use of hyperbaric oxygen and chemical hypoxic cell sensitizers. The Biological Basis of Radiotherapy, G.G. Steel, G.E. Adams, M.J. Peckham. Elsevier, Amsterdam 1983; 225–237
   Google Scholar
• Dische S. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy. Radiotherapy and Oncology 1985; 3: 97–115
   PubMed Web of Science ®Google Scholar
• Dische S., Anderson P.J., Sealy R., Watson E.R. Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygen. British Journal of Radiology 1983; 56: 251–255
   PubMed Web of Science ®Google Scholar
• Dunphy E.P., Petersen I.A., Cox R.S., Bagshaw M.A. The influence of initial hemoglobin concentration and blood pressure levels on results of radiation therapy for carcinoma of the prostate. International Journal of Radiation Oncology, Biology, and Physics 1989; 16: 1173–1178
   PubMed Web of Science ®Google Scholar
• EORTC Cooperative Group of Radiotherapy. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. International Journal of Radiation Oncology, Biology, and Physics 1986; 12: 587–591
   PubMed Web of Science ®Google Scholar
• Fazekas J., Marcial V., Scott C., Jr, Wasserman T., Davis L. Failure of misonidazole to improve outcome in advanced head and neck squamous cancer. International Journal of Radiation Oncology, Biology, and Physics 1986; 12(1)123–124
   PubMedGoogle Scholar
• Fazekas J., Pajak T.F., Wasserman T., Marcial V., Davis L., Kramer S., Rotman M., Stetz J. Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III–IV squamous cancers of the head and neck. International Journal of Radiation Oncology, Biology, and Physics 1987; 13: 1155–1160
   PubMed Web of Science ®Google Scholar
• Gatenby R.A., Kessler H.B., Rosenblum J.S., Coia L.R., Moldofsky P.J., Hartz W.H., Broder G.J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. International Journal of Radiation Oncology, Biology and Physics 1988; 14: 831–838
   PubMed Web of Science ®Google Scholar
• Girinski T., Pejovic-Lenfant M.H., Bourhis J., Campana F., Cosset J.M., Petit C., Malaise E.P., Haie C., Gerbaulet A., Chassagne D. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: Results of a retrospective study of 386 patients. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 37–42
   PubMed Web of Science ®Google Scholar
• Gonzalez Gonzalez D., Van Dijk J.D.P., Van Klinken J.W. Further evidence on the role of the hemoglobin as prognostic factor in carcinoma of the uterine cervix stage IIB and III. 7th Annual Meeting of the European Society for Therapeutic Radiology and Oncology. 1988; 82–82, Abstracts
   Google Scholar
• Gray L.H., Conger A.D., Ebert M., Hornsey S., Scott O.C.A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 1953; 26: 638–648
   PubMed Web of Science ®Google Scholar
• Hatlevoll, R., Lindegaard, K.F., Hagen, S., et al, Scandinavian Glioblastoma Study Group. Combined modality treatment of operated astrocytomas grade 3 and 4. Cancer 1985; 56: 41–47
   PubMed Web of Science ®Google Scholar
• Henk J.M. Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: A rationale for hypoxic cell sensitizers?. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1339–1341
   PubMed Web of Science ®Google Scholar
• Hirst D.G. Anemia: A problem or an opportunity in radiotherapy?. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 2009–2017
   PubMed Web of Science ®Google Scholar
• Horsman M.R., Overgaard J., Christensen K.L., Trotter M.J., Chaplin D.J. Mechanism for the reduction of tumour hypoxia by nicotinamide. Biomedica Biochimica Acta 1989; 48: 5251–5254
   Google Scholar
• Kallman R.F. Reoxygenation and repopulation in irradiated tumors. Frontiers of Radiation Therapy and Oncology 1988; 22: 30–49
   PubMedGoogle Scholar
• Kolstad P. Vascularization, Oxygen Tension, and Radiocurability in Cancer of the Cervix. Norwegian Monographs on Medical Science. Scandinavian University Books, Oslo 1964
   Google Scholar
• Lee D.-J., Pajak T.F., Stetz J., Order S.E., Weissberg J.B., Fischer J.J. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 465–470
   PubMed Web of Science ®Google Scholar
• Leibel S., Bauer M., Wasserman T., Marcial V., Rotman M., Hornback N., Cooper J., Gillespie B., Pakuris E., Conner N., Martin-Durbin L. Radiotherapy with or without misonidazole for patients with stage IIIb or stage IVa squamous cell carcinoma of the uterine cervix: Preliminary report of a radiation therapy oncology group's randomized trial. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 541–549
   PubMed Web of Science ®Google Scholar
• Miraldi F. Potential of NMR and PET for determining tumor metabolism. International Radiation Oncology, Biology and Physics 1986; 12: 1033–1039
   PubMed Web of Science ®Google Scholar
• Nelson D.A., Diener-West M., Weinstein A.S., Schoenfeld D., Nelson J.S., Sause W.T., Chang C.H., Goodman R.T., Carabell S.A. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1793–1800
   PubMed Web of Science ®Google Scholar
• Neumeister K., Revesz L. Advances in hypoxyradiotherapy. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 427–431
   PubMedGoogle Scholar
• Overgaard J. The influence of hemoglobin concentration on the response to radiotherapy. Scandinavian Journal of Clinical Laboratory Investigations 1988; 48(189)49–53
   Google Scholar
• Overgaard J. The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 535–549
   PubMed Web of Science ®Google Scholar
• Overgaard J., Bentzen S.M., Kolstad P., Kjoerstad K., Davy M., Bertelsen K., Mäntylä M., Frankendal B., Skryten A., Löfquist I., Pedersen M., Sell A., Jensen R.H. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix. International Journal of Radiation Oncology, Biology and Physics 1989a; 16: 1069–1072
   PubMed Web of Science ®Google Scholar
• Overgaard J., Nielsen O.S., Lindegaard J.C. Biological basis for rational design of clinical treatment with combined hyperthermia and radiation. Physics and Technology of Hyperthermia. NATO ASI Series E: Applied Sciences No. 127, S.B. Field, C. Franconi. Martinus Nijhoff, Dordrecht, Boston, Lancaster 1987; 54–79
   Google Scholar
• Overgaard J., Sand Hansen H., Andersen A.P., Hjelm-Hansen M., Jørgensen K., Sandberg E., Berthelsen A., Jensen R.H., Pedersen M. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx. Report from the DAHANCA 2 study. International Journal of Radiation Oncology, Biology and Physics 1989b; 16: 1065–1068
   PubMed Web of Science ®Google Scholar
• Overgaard J., Sand Hansen H., Jørgensen K., Hjelm-Hansen M. Primary radiotherapy of larynx and pharynx carcinoma. An analysis of factors influencing local control and survival. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 515–521
   PubMed Web of Science ®Google Scholar
• Panduro J., Kjaer M., Wolff-Jensen J., Hansen H.H. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. Cancer 1983; 52: 20–24
   PubMed Web of Science ®Google Scholar
• Revesz L., Balmukhanov S., Sharipova M., Kolycheva N. (1987) Vascularity as a predictor of radiation response: Its possible practical usefulness in selecting cases for treatment with radiosensitisers. Proceedings of the Third Meeting on Progress in Radio-Oncology, ViennaAustria, 1985. International Club for Radio-Oncology, Austria, 97–100
   Google Scholar
• Rofstad E.K., Fenton B.M., Sutherland R.M. Intracapillary HbO2 saturations in murine tumours and human tumour xenografts measured by cryospectrophotometry: Relationship to tumour volume, tumour pH and fraction of radiobiologically hypoxic cells. British Journal of Cancer 1988; 57: 494–502
   PubMed Web of Science ®Google Scholar
• Sasai K., Ono K., Hiraoka M., Tsutsui K., Shibamoto Y., Takahashi M., Hamakawa J., Nadai C., Abe M. The effect of arterial oxygen content on the results of radiation therapy for epidermoid bronchogenic carcinoma. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 1477–1481
   PubMed Web of Science ®Google Scholar
• Schwarz G. Ueber Desensibilisierung gegen Röntgen- und Radiumstrahlen. Münchener Medizinische Wochenschrift 1909; 24: 1–2
   Google Scholar
• Simpson J.R., Bauer M., Wasserman T.H., Perez C.A., Emami B., Wiegenberg I., Zinninger M., Martin Durbin L. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 861–867
   PubMed Web of Science ®Google Scholar
• Simpson J.R., Bauer M., Perez C.A., Wasserman T.H., Emami B., Scott Doggett R.L., Byhardt R.W., Phillips T.L., Mowry P.H. Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial. International Journal of Radiation Oncology, Biology, Physics 1989; 16: 1483–1491
   PubMed Web of Science ®Google Scholar
• Stratford I.J., Sheldon P.W., Adams G.E. Hypoxic cell radiosensitizers. The Biological Basis of Radiotherapy. Elsevier, Amsterdam 1983; 211–223
   Google Scholar
• Suit H.D. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 1982; 50: 1227–1234
   PubMed Web of Science ®Google Scholar
• Suit H., Lindberg R. Radiation therapy administered under conditions of tourniquet-induced local tissue hypoxia. American Journal of Roentgenology 1967; 102: 27–37
   Web of Science ®Google Scholar
• Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. British Journal of Cancer 1955; 9: 539–549
   PubMed Web of Science ®Google Scholar
• Urtasun R.C., Band P., Chapman J.D., Feldstein M., Mielke B., Fryer C. Radiation and high dose metronidazole (Flagyl) in supratentorial glioblastomas. New England Journal of Medicine 1976; 293: 1364–1367
   Google Scholar
• Urtasun R.C., Chapman J.D., Raleigh J.A., Franko A.J., Koch C.J. Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1263–1267
   PubMed Web of Science ®Google Scholar